Scientists probe new Drug's attack on autoimmune dryness
NCT ID NCT05124925
Summary
This study aimed to understand how the experimental drug ianalumab works in people with Sjögren's syndrome, an autoimmune disease that causes severe dryness. Researchers gave the drug to 21 patients and took small saliva gland samples to see how it affected immune cells. The main goal was to learn how the drug behaves in the body and whether it's safe, not to prove it relieves symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Brest, 29200, France
Conditions
Explore the condition pages connected to this study.